Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival

• Published in: Gynecologic oncology Vol. 145; no. 3; pp. 500 - 507
• Main Authors: Barber, Emma L, Dusetzina, Stacie B, Stitzenberg, Karyn B, Rossi, Emma C, Gehrig, Paola A, Boggess, John F, Garrett, Joanne M
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2017
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant - statistics & numerical data; Cohort Studies; Female; Hematology, Oncology and Palliative Medicine; Hospital utilization; Hospitals, High-Volume - statistics & numerical data; Humans; Logistic Models; Middle Aged; Neoadjuvant chemotherapy; Neoadjuvant Therapy - statistics & numerical data; Neoplasm Staging; Neoplasms, Glandular and Epithelial - drug therapy; Neoplasms, Glandular and Epithelial - epidemiology; Neoplasms, Glandular and Epithelial - pathology; Neoplasms, Glandular and Epithelial - surgery; Obstetrics and Gynecology; Ovarian cancer; Ovarian Neoplasms - drug therapy; Ovarian Neoplasms - epidemiology; Ovarian Neoplasms - pathology; Ovarian Neoplasms - surgery; Patterns of care; United States - epidemiology; Young Adult; United States; Neoadjuvant chemotherapy; Hospital utilization; Patterns of care; Ovarian cancer
• ISSN: 0090-8258; 1095-6859
• DOI: 10.1016/j.ygyno.2017.03.014

Highlights • Neoadjuvant chemotherapy use varied widely, from 5 to 55%, among high volume hospitals. • Hospital level patterns of neoadjuvant chemotherapy use are associated with survival. • Hospitals with low neoadjuvant chemotherapy utilization had decreased survival.